Patent delisted for Boehringer Ingelheim drug TRADJENTA

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post Patent delisted for Boehringer Ingelheim drug TRADJENTA…


Patent delisted for Acorda drug AMPYRA

Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog